Catalent, Inc

Catalent, Inc is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. With a commitment to innovation and quality, Catalent partners with pharmaceutical and biotechnology companies to enhance the effectiveness of their products.

Founded in 2007, the company has rapidly expanded its capabilities and services, establishing a strong presence in the UK and worldwide. Catalent’s state-of-the-art facilities are equipped with cutting-edge technology, enabling them to offer a wide range of services including drug formulation, clinical supply, and commercial manufacturing.

The company is dedicated to improving patient outcomes by providing tailored solutions that meet the unique needs of its clients. Catalent’s expertise spans various dosage forms, including oral, injectable, and inhalation products, ensuring that they can support a diverse portfolio of therapies.

In addition to its manufacturing capabilities, Catalent invests heavily in research and development, striving to stay at the forefront of industry advancements. The company’s vision is to be the partner of choice for life sciences companies, helping them bring their products to market faster and more efficiently.

With a strong focus on sustainability and corporate responsibility, Catalent is committed to reducing its environmental impact while delivering high-quality products. The company’s workforce is comprised of highly skilled professionals who are passionate about making a difference in the healthcare sector.

As Catalent continues to grow, it remains focused on its mission to provide innovative solutions that improve the lives of patients around the world.